{"title": "Global Advisory Committee on Vaccine Safety, June 2012 - PubMed", "author": "Username", "url": "https://pubmed.ncbi.nlm.nih.gov/22905369/", "hostname": "ncbi.nlm.nih.gov", "description": "Global Advisory Committee on Vaccine Safety, June 2012", "sitename": "PubMed", "date": "2012-07-27", "cleaned_text": "Global Advisory Committee on Vaccine Safety, June 2012 - PMID: 22905369 Global Advisory Committee on Vaccine Safety, June 2012 Similar articles - [Global Advisory Committee on Vaccine Safety, December 2011.](/22355832/)Wkly Epidemiol Rec. 2012 Feb 10;87(6):53-9. Wkly Epidemiol Rec. 2012. PMID: 22355832 English, French. No abstract available. - [Global Advisory Committee on Vaccine Safety,12-13 June 2013.](/23909011/)Wkly Epidemiol Jul 19;88(29):301-12. Wkly Epidemiol Rec. 2013. PMID: 23909011 English, French. No abstract available. - [Meeting of Global Advisory Committee on Vaccine Safety, 18-19 June 2008.](/18689006/)Wkly Epidemiol Rec. 2008 Aug 8;83(32):287-92. Wkly Epidemiol Rec. 2008. English, Review. - [Hypersensitivity reactions to vaccine constituents: a case series and review of the literature.](/22653170/)Dermatitis. 2012 May-Jun;23(3):102-9. doi: 10.1097/DER.0b013e31825228cf. Dermatitis. 2012. PMID: 22653170 Review. Cited by - [Vaccine safety issues at the turn of the 32226055 Free PMC and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase 31810418 Free PMC article. Clinical Trial. - [Vaccination in children with allergy to non active vaccine components.](/25852819/)Clin Transl Med. 2015 Feb - [The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level.](/25378762/)Bull World Health Organ. 2014 Sep 1;92(9):695-6. doi: 10.2471/BLT.14.138875. Epub 2014 Jul 31. Bull World Health Organ. 2014. PMID: 25378762 Free PMC article. No abstract available. MeSH terms Substances LinkOut - more resources Full Text Sources Medical "}